Glycemic Excursion Minimization for Black adults with type 2 diabetes
Glycemic Excursion Minimization (GEM) to Outshine Health Disparities: RCT
This study is testing a coaching program to help Black adults with type 2 diabetes lower their blood sugar by eating less carbs and being more active after meals.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 25 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Augusta University Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (Augusta, Georgia) |
| Trial ID | NCT06236581 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility and acceptability of the GEM intervention, which involves coaching to reduce carbohydrate intake and increase physical activity after meals, supported by feedback from continuous glucose monitoring. The focus is on Black adults with type 2 diabetes who are not on insulin or secretagogues. The intervention seeks to improve blood glucose levels, reduce diabetes distress, and enhance empowerment in managing diabetes. Participants will receive tailored support to help them make dietary and lifestyle changes.
Who should consider this trial
Good fit: Ideal candidates for this study are Black adults diagnosed with type 2 diabetes who are capable of making dietary and physical activity changes.
Not a fit: Patients who are on insulin or secretagogues, or those with conditions that impede weight loss, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to better blood glucose control and improved quality of life for Black adults with type 2 diabetes.
How similar studies have performed: Other studies have shown promise in using continuous glucose monitoring and lifestyle interventions for diabetes management, indicating that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * type 2 diabetes * capable of making dietary and physical activity changes Exclusion Criteria: * on insulin or secretagogue * on medications that impede weight loss (e.g., prednisone) * pregnant or planning pregnancy in the next 2 months * no history of moderate to severe hypoglycemia
Where this trial is running
Augusta, Georgia
- Georgia Prevention Institute — Augusta, Georgia, United States (Recruiting)
Study contacts
- Principal investigator: Catherine L Davis, PhD — Augusta University
- Study coordinator: Catherine L Davis, PhD
- Email: katie.davis@augusta.edu
- Phone: 706-721-4534
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.